Joel Latham is CEO and President of Incannex Healthcare Ltd. Currently has a direct ownership of 24.2 Million shares of IXHL, which is worth approximately $8.47 Million. The most recent transaction as insider was on Nov 14, 2025, when has been sold 22,608,692 shares (Common Stock, $0.0001 par value per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 24.2M
1433.21% 3M change
1433.21% 12M change
Total Value Held $8.47 Million

Joel Latham Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 14 2025
BUY
Grant, award, or other acquisition
-
22,608,692 Added 48.31%
24,186,177 Common Stock, $0.0001 ...
Dec 21 2023
BUY
Grant, award, or other acquisition
-
1,340,000 Added 45.93%
1,577,485 Common Stock
JL

Joel Latham

CEO and President
Norwest, New South Wales, C3

Track Institutional and Insider Activities on IXHL

Follow Incannex Healthcare Ltd and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IXHL shares.

Notify only if

Insider Trading

Get notified when an Incannex Healthcare LTD insider buys or sells IXHL shares.

Notify only if

News

Receive news related to Incannex Healthcare Ltd

Track Activities on IXHL